Federal officials say a COVID-19 vaccine for younger children could be approved as early as this month.
Health Canada wrote on Twitter on Tuesday that it expects to make a decision by mid-July on whether to approve Moderna’s vaccine for children six months to five years old.
Moderna requested that its vaccine be given in two doses, each representing a quarter of its adult dose, given about four weeks apart.
The agency says it received a submission from Pfizer-BioNTech on June 23 for its vaccine for children aged six months to four years.
A Health Canada spokesperson said regulators are still setting a timeline for their review of Pfizer-BioNTech’s application.
Canada has yet to authorize a vaccine for its nearly two million children under the age of five.
Pfizer-BioNTech’s Comirnaty vaccine can be used on children as young as five years old, and Moderna’s Spikevax vaccine has been approved for children six and older.
To see in video